Literature DB >> 18808452

Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.

Tomás R Guilarte1, Neal C Burton, Jennifer L McGlothan, Tatyana Verina, Yun Zhou, Mohab Alexander, Luu Pham, Michael Griswold, Dean F Wong, Tore Syversen, Jay S Schneider.   

Abstract

The long-term consequences of chronic manganese (Mn) exposure on neurological health is a topic of great concern to occupationally-exposed workers and in populations exposed to moderate levels of Mn. We have performed a comprehensive assessment of Mn effects on dopamine (DA) synapse markers using positron emission tomography (PET) in the non-human primate brain. Young male Cynomolgus macaques were given weekly i.v. injections of 3.3-5.0 mg Mn/kg (n = 4), 5.0-6.7 mg Mn/kg (n = 5), or 8.3-10.0 mg Mn/kg (n = 3) for 7-59 weeks and received PET studies of various DA synapse markers before (baseline) and at one or two time points during the course of Mn exposure. We report that amphetamine-induced DA release measured by PET is markedly impaired in the striatum of Mn-exposed animals. The effect of Mn on DA release was present in the absence of changes in markers of dopamine terminal integrity determined in post-mortem brain tissue from the same animals. These findings provide compelling evidence that the effects of Mn on DA synapses in the striatum are mediated by inhibition of DA neurotransmission and are responsible for the motor deficits documented in these animals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18808452      PMCID: PMC3675778          DOI: 10.1111/j.1471-4159.2008.05695.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  51 in total

Review 1.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

2.  Exposure to manganese: health effects on the general population, a pilot study in central Mexico.

Authors:  C Santos-Burgoa; C Rios; L A Mercado; R Arechiga-Serrano; F Cano-Valle; R A Eden-Wynter; J L Texcalac-Sangrador; J P Villa-Barragan; Y Rodriguez-Agudelo; S Montes
Journal:  Environ Res       Date:  2001-02       Impact factor: 6.498

3.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

4.  Levodopa failure in chronic manganism.

Authors:  C S Lu; C C Huang; N S Chu; D B Calne
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

5.  Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study.

Authors:  Tomás R Guilarte; Jennifer L McGlothan; Mahaveer Degaonkar; Ming-Kai Chen; Peter B Barker; Tore Syversen; Jay S Schneider
Journal:  Toxicol Sci       Date:  2006-09-12       Impact factor: 4.849

6.  Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates.

Authors:  Tomás R Guilarte; Ming-Kai Chen; Jennifer L McGlothan; Tatyana Verina; Dean F Wong; Yun Zhou; Mohab Alexander; Charles A Rohde; Tore Syversen; Emmanuel Decamp; Amy Jo Koser; Stephanie Fritz; Heather Gonczi; David W Anderson; Jay S Schneider
Journal:  Exp Neurol       Date:  2006-08-22       Impact factor: 5.330

7.  Parkinsonism caused by chronic usage of intravenous potassium permanganate.

Authors:  Hasan Meral; Yasar Kutukcu; Birgul Atmaca; Feriha Ozer; Kemal Hamamcioglu
Journal:  Neurologist       Date:  2007-03       Impact factor: 1.398

8.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.

Authors:  Sreeganga Chandra; Gilbert Gallardo; Rafael Fernández-Chacón; Oliver M Schlüter; Thomas C Südhof
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

Review 9.  Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy.

Authors:  R F Butterworth; L Spahr; S Fontaine; G P Layrargues
Journal:  Metab Brain Dis       Date:  1995-12       Impact factor: 3.584

10.  A Parkinsonian syndrome in methcathinone users and the role of manganese.

Authors:  Ainārs Stepens; Ināra Logina; Viesturs Liguts; Pauls Aldins; Ilze Eksteina; Ardis Platkājis; Inese Mārtinsone; Elmārs Tērauds; Baiba Rozentāle; Michael Donaghy
Journal:  N Engl J Med       Date:  2008-03-06       Impact factor: 91.245

View more
  61 in total

1.  Mechanisms of lead and manganese neurotoxicity.

Authors:  April P Neal; Tomas R Guilarte
Journal:  Toxicol Res (Camb)       Date:  2013-03-01       Impact factor: 3.524

2.  Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water.

Authors:  Saritha Krishna; Celia A Dodd; Shahryar K Hekmatyar; Nikolay M Filipov
Journal:  Arch Toxicol       Date:  2013-07-06       Impact factor: 5.153

Review 3.  Manganese and its role in Parkinson's disease: from transport to neuropathology.

Authors:  Michael Aschner; Keith M Erikson; Elena Herrero Hernández; Elena Herrero Hernández; Ronald Tjalkens
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

4.  Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain.

Authors:  Neal C Burton; Jay S Schneider; Tore Syversen; Tomás R Guilarte
Journal:  Toxicol Sci       Date:  2009-06-10       Impact factor: 4.849

5.  Age-dependent susceptibility to manganese-induced neurological dysfunction.

Authors:  Julie A Moreno; Elizabeth C Yeomans; Karin M Streifel; Bryan L Brattin; Robert J Taylor; Ronald B Tjalkens
Journal:  Toxicol Sci       Date:  2009-10-07       Impact factor: 4.849

6.  Ex vivo magnetic resonance imaging in South African manganese mine workers.

Authors:  Susan R Criswell; Gill Nelson; Luis F Gonzalez-Cuyar; John Huang; Joshua S Shimony; Harvey Checkoway; Christopher D Simpson; Russell Dills; Noah S Seixas; Brad A Racette
Journal:  Neurotoxicology       Date:  2015-04-23       Impact factor: 4.294

7.  Effects of chronic manganese exposure on attention and working memory in non-human primates.

Authors:  J S Schneider; C Williams; M Ault; T R Guilarte
Journal:  Neurotoxicology       Date:  2015-04-24       Impact factor: 4.294

8.  Postnatal manganese exposure does not alter dopamine autoreceptor sensitivity in adult and adolescent male rats.

Authors:  Sanders A McDougall; Alena Mohd-Yusof; Graham J Kaplan; Zuhair I Abdulla; Ryan J Lee; Cynthia A Crawford
Journal:  Eur J Pharmacol       Date:  2013-02-28       Impact factor: 4.432

9.  Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin.

Authors:  Jerome A Roth; Balakrishnan Ganapathy; Andrew J Ghio
Journal:  Toxicol In Vitro       Date:  2012-07-26       Impact factor: 3.500

10.  BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity.

Authors:  Kirstie H Stansfield; Terry Jo Bichell; Aaron B Bowman; Tomás R Guilarte
Journal:  J Neurochem       Date:  2014-09-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.